Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Asymchem Laboratories Tianjin (6821 HK)
Watchlist
48
Analysis
Health Care
•
China
Asymchem Laboratories (Tianjin) Co., Ltd. operates as a pharmaceutical company. The Company researches, produces, and sells organic and inorganic chemicals, medicines, and other related products. Asymchem Laboratories serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
03 Oct 2023 08:00
Hong Kong Connect Flows: $7.3bn of Inflows in September
We analyzed the Hong Kong Connect Scheme for September and highlight flows for ICBC, CCB, Meituan, Innovent Biologics, Xpeng and Petrochina.
Ke Yan, CFA, FRM
Follow
356 Views
Share
bullish
•
Innovent Biologics Inc
•
11 Sep 2023 21:11
Innovent Biologics Placement - Has Ample Cash but the Discount Is Enticing
Innovent Biologics Inc (1801 HK) (IB) aims to raise around US$313m for R&D and marketing. In this note, we talk about the deal dynamics and run the...
Sumeet Singh
Follow
502 Views
Share
bearish
•
WuXi AppTec
•
31 Jul 2023 09:06
WuXi AppTec (603259.CH/2359.HK) 2022H1 - The Concerns Behind and the Outlook
In this insight last year, we expressed our concerns on WuXi AppTec's performance in 2023, when we think could be the performance low point. So,...
Xinyao (Criss) Wang
Follow
456 Views
Share
bearish
•
Quantitative Analysis
•
23 Jul 2023 10:05
A-H Premium Weekly (Jul 21st): China Vanke, New China Life, BYD, CMOC, Asymchem, Huaneng
We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Vanke, New China Life, BYD, CMOC, Asymchem, Huaneng,...
Ke Yan, CFA, FRM
Follow
467 Views
Share
bullish
•
Quantitative Analysis
•
09 Jul 2023 10:10
A-H Premium Weekly (Jul 7th): BankComm, ICBC, CCB, BYD, Asymchem, Hisense, Baiyunshan
We analyzed A-H premium changes in the past week and highlight A-H premium changes for BankComm, ICBC, CCB, BYD, Asymchem, Hisense, Baiyunshan,...
Ke Yan, CFA, FRM
Follow
546 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x